Genericos Centroamericanos, S.A. III
Category C projects are those that are likely to result in very limited or no adverse environmental or social impacts or risks.
Projected date at which a project will be put forward for the Board of Executive Directors’ approval.
Projected board date
USD $ 275,000
Project scope and objective
A loan of US$275,000 from the Inter-American Investment Corporation (IIC) to Nicaraguan company Genéricos Centroamericanos, S.A. (Generifar) will enable this small enterprise to meet the growing domestic and international demand for its chemical and pharmaceutical products for human consumption.
For inquiries, comments and information requests about the projectRequest information
Alternatively, you may also use the following contact information:
IDB Invest Contact
1350 New York Ave NW, Washington, DC 20005